SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053565
Filing Date
2021-11-02
Accepted
2021-11-02 16:16:21
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20210930.htm   iXBRL 10-Q 3163139
2 EX-10.1 rgnx-ex101_128.htm EX-10.1 960434
3 EX-31.1 rgnx-ex311_7.htm EX-31.1 16938
4 EX-31.2 rgnx-ex312_6.htm EX-31.2 16909
5 EX-32.1 rgnx-ex321_8.htm EX-32.1 11304
  Complete submission text file 0001564590-21-053565.txt   13020407

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210930.xsd EX-101.SCH 61586
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20210930_cal.xml EX-101.CAL 63027
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20210930_def.xml EX-101.DEF 207514
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210930_lab.xml EX-101.LAB 473425
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210930_pre.xml EX-101.PRE 360478
11 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-10q_20210930_htm.xml XML 2844752
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 211371513
SIC: 2836 Biological Products, (No Diagnostic Substances)